Manufacturing & Capabilities — Stancor Pharma

Stancor Pharma combines modern manufacturing, processing and quality infrastructure to deliver contract and outsource pharmaceutical manufacturing — contrast media, oncology injectables, biosimilar development programmes, cosmetics, general injectables and oral dosage forms to exacting international standards.

Capabilities

• Contrast media — iodinated and gadolinium-based imaging agents, large volume aseptic fill
• Oncology injectables — cytotoxic liquid and lyophilised vials in a contained suite
• Biosimilar programmes — development-stage formulation, fill-finish and comparability support
• Cosmetics — creams, serums, gels, lotions and cleansers under ISO 22716
• General injectables — vials, ampoules, pre-filled syringes, lyophilised
• Oral solids and liquids — tablets, capsules, syrups, suspensions and dry powders
• Heat treatment, cutting and finishing to specification

Quality & testing

Solution annealing, hydrostatic testing, NDT (UT, RT, PT, MT), PMI, IGC and full traceability with EN 10204 3.1/3.2 certification.

Standards

ASTM/ASME, API, EN/DIN and JIS across austenitic, duplex, super-duplex and nickel-alloy grades.

For availability, a full release data pack and a capability and capacity response, contact Stancor Pharma.